financetom
Business
financetom
/
Business
/
Robinhood To Acquire Canada's WonderFi For $178M All-Cash Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Robinhood To Acquire Canada's WonderFi For $178M All-Cash Deal
May 26, 2025 6:45 AM

Robinhood Markets, Inc. ( HOOD ) has signed an agreement to acquire WonderFi Technologies Inc., a Canadian cryptocurrency platform, in an all-cash transaction valued at approximately $178 million.

What Happened: The purchase price of $0.26 per share represents a 41 percent premium over WonderFi's closing price on May 12 and a 71 percent premium over its 30-day volume-weighted average price, according to a company statement.

WonderFi operates Bitbuy and Coinsquare, two regulated cryptocurrency exchanges in Canada, with a reported $1.49 billion in assets under custody.

The company will continue operating its platforms after the transaction closes.

The deal is expected to be completed in the second half of 2025, subject to shareholder approval, regulatory review and court authorization.

Robinhood, which opened a Canadian headquarters in Toronto in 2024, will incorporate WonderFi's operations into its existing crypto business.

According to the agreement, WonderFi's leadership team is expected to remain with the company following the acquisition.

Employees will be added to Robinhood's Canadian workforce, which currently includes over 140 people.

Also Read: Coinbase Could See Up To $16B Net Inflows After S&P 500 Entry: Bernstein

The acquisition will be carried out under a statutory plan of arrangement governed by British Columbia corporate law.

Robinhood plans to fund the purchase using existing cash reserves. No stock issuance or debt financing will be used to support the transaction.

WonderFi shareholders will receive the full purchase amount in cash.

The company's common shares are currently listed on the Toronto Stock Exchange. The combined equity value of the transaction, on a fully diluted basis, stands at approximately $178 million.

Advisors on the deal include J.P. Morgan Securities for Robinhood and Financial Technology Partners for WonderFi.

Legal counsel was provided by Canadian firms on both sides, including Goodmans LLP, Cassels Brock & Blackwell LLP, and Mintz LLP.

Read Next:

Cardano Up 23% In 7 Days As Co-Founder Charles Hoskinson Explores Privacy-Focused Stablecoin

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Western Digital Expands SIT Lab For AI Boom
Western Digital Expands SIT Lab For AI Boom
Oct 13, 2025
Western Digital Corporation ( WDC ) shares are trading higher on Monday. The company announced the opening of its expanded System Integration and Test (SIT) Lab. The lab, spanning a 25,600-square-foot facility, is designed to accelerate customer adoption and deliver faster time-to-value. WDC is demonstrating strength. Get the inside scoop here. The new lab addresses growing AI storage demands by...
Datavault AI Buys NYIAX To Fuse AI And Blockchain
Datavault AI Buys NYIAX To Fuse AI And Blockchain
Oct 13, 2025
Datavault AI Inc. ( DVLT ) said it will acquire NYIAX Inc. in a deal that combines AI-based data monetization with blockchain-powered trading. The transaction, pending approval from Nasdaq and shareholders, will add NYIAX’s exchange technology and patents to Datavault AI’s portfolio. The move follows an earlier licensing deal for NYIAX’s ADIO ultrasonic technology, which is now being fully integrated...
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Monday its experimental gene therapy ABO-503 was accepted into the US Food and Drug Administration' Rare Disease Endpoint Advancement Pilot Program, which aims to speed up development of treatments for rare conditions. ABO-503 targets X-linked retinoschisis, a genetic eye disease that affects retinal structure and function. The...
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Oct 13, 2025
10:33 AM EDT, 10/13/2025 (MT Newswires) -- Pacific Biosciences of California ( PACB ) said Monday that its HiFi sequencing technology has been selected as the primary platform for South Korea's pangenome reference project. The company said it will provide integrated sequencing services across the workflow under the project, an initiative led by Korea National Institute of Health to sequence...
Copyright 2023-2026 - www.financetom.com All Rights Reserved